Microsoft Corporation
$3.63T- Market cap
- $3.66T
- Debt
- +$49.52B
- Cash
- −$76.84B
Capital structure 99% equity / 1% debt · EV / Revenue 10.95x · EV / EBITDA 17.73x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: MSFT stock price at premium vs SUPN $493.06 current versus $154.89 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SUPN's multiple
Implied fair value · at MSFT's multiple
Snapshot Sep 8, 10:58 AM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MSFT FY 2026 (ended Jun 30, 2026) · SUPN FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 99% equity / 1% debt · EV / Revenue 10.95x · EV / EBITDA 17.73x
Capital structure 98% equity / 2% debt · EV / Revenue 3.35x · EV / EBITDA 49.73x
MSFT carries the larger enterprise value at $3.63T against $2.41B; SUPN trades on the lower EV / Revenue multiple (3.35x vs 10.95x); MSFT on the lower EV / EBITDA (17.73x vs 49.73x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
MICROSOFT CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
SUPERNUS PHARMACEUTICALS, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.11x
0.04x
Net debt / EBITDA
Leverage against operating earnings
-0.13x
-1.75x
Cash and equivalents
Liquid reserves on the balance sheet
$76.84B
$128.45M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Apple Inc.
MSFT vs AAPL
Alphabet Inc.
MSFT vs GOOGL
AMAZON COM INC
MSFT vs AMZN
ADOBE INC.
MSFT vs ADBE
NVIDIA CORP
MSFT vs NVDA
CISCO SYSTEMS, INC.
MSFT vs CSCO
Jazz Pharmaceuticals plc
MSFT vs JAZZ
INCYTE CORP
MSFT vs INCY
ANI PHARMACEUTICALS INC
MSFT vs ANIP
Vanda Pharmaceuticals Inc.
MSFT vs VNDA
Harmony Biosciences Holdings, Inc.
MSFT vs HRMY
$49.52B
$43.80M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.